Centrus Secures $900M HALEU Enrichment Contract, Bringing Total Value to $1.07B
0xBroomberg
Centrus Energy (LEU) signed a $900 million fixed-price contract with the U.S. Department of Energy to deploy commercial-scale HALEU production in Ohio — marking the formal shift of America's advanced nuclear-fuel supply chain from demonstration to commercial deployment.
What does this contract actually cover?
The core deliverable is a commercial-scale production line for HALEU — high-assay low-enriched uranium, the higher-concentration fuel required by next-generation reactors — at the Piketon, Ohio site.
Fixed price: $900 million. If DOE exercises all procurement options, total value reaches $1.07 billion, including up to $170 million in HALEU purchase options.
This means → DOE is not just funding construction; it has reserved the right to buy output directly — locking in both capacity and supply in one move.
How did the demonstration phase go?
Centrus completed all production obligations under the prior demonstration contract. The final 900 kg of HALEU uranium hexafluoride (UF6) was delivered in mid-June, two weeks ahead of schedule.
Cumulative output over the contract's life exceeded 1,900 kg.
In plain terms = this was a graduation exam — delivering on time, even early, is what earned the commercial-scale contract now in hand.
How large is the new capacity?
Initial buildout targets 12 metric tons of HALEU per year, while also serving Centrus's existing $2.4 billion backlog of low-enriched uranium (LEU) orders.
The company says HALEU and LEU capacity can expand further based on market demand; it expects to reach economies-of-scale cost levels in centrifuge manufacturing once initial buildout is complete.
This means → 12 metric tons is the starting point. The real capacity ceiling depends on downstream demand — and a $2.4 billion LEU backlog shows demand is already queuing up.
How is the transition period bridged?
Centrus and DOE separately signed a $15 million, three-month HALEU storage extension agreement.
This reflects a gap between the old and new contracts; the interim deal ensures HALEU already produced is safely stored during the buildout window with no supply interruption.
What comes next?
From winning the demonstration contract in 2019, through a 2022 extension, to the commercial contract now — Centrus spent six years moving from lab to factory.
Whether DOE exercises the $170 million purchase option will be the key signal testing real market demand.
Put simply = a signed contract does not mean the full value is locked in. Whether the purchase option is activated is the litmus test for whether this supply chain is driven by genuine demand or policy momentum alone.
Content is for reference only, not financial advice.